Masculini-T
On sale on the US market (according to the DSLD)
LifeSeasons Therapeutics, food supplement from the US market
Masculini-T (LifeSeasons Therapeutics), a food supplement au code-barres 853760002247, is described by its US market label. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- LifeSeasons Therapeutics
- Barcode
- 853760002247
- Form
- Capsule
- One serving
- 3 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Hypromellose, Rice Bran
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Tribulus Fruit Extract (Tribulus terrestris) | Plant | 400 mg |
| Saponins | Other substance | 180 mg |
| Fenusterol (Trigonella foenum-graecum) | Plant | 400 mg |
| Saponins | Other substance | 200 mg |
| Maca Root Extract (Lepidium meyenii) | Plant | 300 mg |
| Horny Goat Weed Extract | Plant | 200 mg |
| Flavones | Other substance | 20 mg |
| LongJaX (Eurycoma longifolia) | Plant | 100 mg |
| Muira puama Root Extract (Ptychopetalum olacoides) | Plant | 100 mg |
| Oatstraw extract (Avena sativa) | Plant | 100 mg |
| Korean Ginseng | Plant | 100 mg |
| Ginkgo Leaf Extract | Plant | 60 mg |
| Flavone Glycosides | Other substance | 14.4 mg |
| Terpene Lactones | Other substance | 3.6 mg |
| Catuaba bark extract | Plant | 50 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Masculini-T
Entered into DSLD on 22 May 2021. Withdrawn from the US market on 13 March 2023 (according to the DSLD).- Active ingredient added : Vitamin B3 (5 mg)
- Active ingredient removed : Flavone Glycosides (14.4 mg)
- Active ingredient removed : Flavones (20 mg)
- Active ingredient removed : Saponins (180 mg)
- Active ingredient removed : Saponins (200 mg)
- Active ingredient removed : Terpene Lactones (3.6 mg)
- Same quantity, different name: Fenugreek seed extract in this version; Fenusterol on the displayed label (400 mg)
- Same quantity, different name: Longjax extract in this version; LongJaX on the displayed label (100 mg)
Official label: Masculini-T
Entered into DSLD on 23 April 2020. Withdrawn from the US market on 19 March 2021 (according to the DSLD).- Active ingredient added : Vitamin B3 (5 mg)
- Active ingredient removed : Flavone Glycosides (14.4 mg)
- Active ingredient removed : Flavones (20 mg)
- Active ingredient removed : Saponins (180 mg)
- Active ingredient removed : Saponins (200 mg)
- Active ingredient removed : Terpene Lactones (3.6 mg)
- Same quantity, different name: Fenugreek seed extract in this version; Fenusterol on the displayed label (400 mg)
- Same quantity, different name: Longjax extract in this version; LongJaX on the displayed label (100 mg)
Official label: Masculini-T Testosterone Support
Entered into DSLD on 25 July 2014. Withdrawn from the US market on 7 October 2019 (according to the DSLD).- Active ingredient added : Fenugreek extract (400 mg)
- Active ingredient added : Gingko biloba extract 24/6 (quantity not stated)
- Active ingredient added : Longjax extract 20:1 (100 mg)
- Active ingredient added : Muira Puama extract (100 mg)
- Active ingredient added : Niacin (5 mg)
- Active ingredient added : Oat Straw extract 10:1 (100 mg)
- Active ingredient added : Tribulus terrestris (400 mg)
- Active ingredient removed : Fenusterol (400 mg)
- Active ingredient removed : Flavone Glycosides (14.4 mg)
- Active ingredient removed : Flavones (20 mg)
- Active ingredient removed : Ginkgo Leaf Extract (60 mg)
- Active ingredient removed : LongJaX (100 mg)
- Active ingredient removed : Muira puama Root Extract (100 mg)
- Active ingredient removed : Oatstraw extract (100 mg)
- Active ingredient removed : Saponins (180 mg)
- Active ingredient removed : Saponins (200 mg)
- Active ingredient removed : Terpene Lactones (3.6 mg)
- Active ingredient removed : Tribulus Fruit Extract (400 mg)
- Same quantity, different name: Catuaba extract 4:1 in this version; Catuaba bark extract on the displayed label (50 mg)
- Same quantity, different name: Maca extract 5:1 in this version; Maca Root Extract on the displayed label (300 mg)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Tribulus Fruit Extract
Read the warning, when it applies and the studies cited
TRIBULUS - TRIBULUS TERRESTRIS
Route of administration: Oral
Cautions and warnings
Condition of application: All products except Vrsya (aphrodisiac for men).
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Chen and Chen 2004).
Sources cited by Health Canada (1)
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
Condition of application: Traditional Chinese Medicine.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have qi or blood deficiency (Bensky et al. 2004).
Sources cited by Health Canada (1)
- Bensky D, Clavey S, Toger E, Gamble A, editors. Chinese Herbal Medicine Materia Medica. 3rd edition. Seattle (WA): Eastland Press Inc; 2004.
Contraindications
Condition of application: Traditional Chinese Medicine.
Do not use if you have low blood pressure or liver deficiency (Bensky et al. 2004; Chen and Chen 2004).
Sources cited by Health Canada (2)
- Bensky D, Clavey S, Toger E, Gamble A, editors. Chinese Herbal Medicine Materia Medica. 3rd edition. Seattle (WA): Eastland Press Inc; 2004.
- Chen JK, Chen TT. Chinese Medical Herbology and Pharmacology. Crampton L, editor. City of Industry (CA): Art of Medicine Press Inc.; 2004.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occurs (Bensky et al. 2004)
Sources cited by Health Canada (1)
- Bensky D, Clavey S, Toger E, Gamble A, editors. Chinese Herbal Medicine Materia Medica. 3rd edition. Seattle (WA): Eastland Press Inc; 2004.
Condition of application: All products except Mutrala (diuretic).
When using this product diuretic effect may occur.
- Fenusterol
Read the warning, when it applies and the studies cited
FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant (Gardner and McGuffin 2013; Brinker 2010; Mills et al. 2006; Hoffman 2003; Blumenthal et al. 2000).
Sources cited by Health Canada (4)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Boston (MA): Integrative Medicine Communications; 2000.
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. 2nd edition. Boca Ration (FL): Taylor and Francis Group; 2013.
- Mills E, Duguoa J, Perri D, Koren G. Herbal Medicines in Pregnancy and Lactation. An Evidence-Based Approach. New York (NY): Taylor and Francis; 2006.
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Mills and Bone 2005).
Sources cited by Health Canada (2)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Mills S, Bone K. The Essential Guide to Herbal Safety. St. Louis (MO): Elsevier Churchill Livingstone; 2005.
Health Canada monograph dated 29 May 2026
FENUGREEK - TRIGONELLA FOENUM-GRAECUM - Topical
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
- Maca Root Extract
Read the warning, when it applies and the studies cited
Maca - Lepidium Meyenii
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Applies to products providing 0.6 g or more dried root/hypocotyl, per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a blood pressure condition (Valentova et al. 2008).
Sources cited by Health Canada (1)
- Valentova K, Stejskal D, Bartek J, Dvoráckova S, Kren V, Ulrichova J, Simanek V. Maca (Lepidium meyenii) and yacon (Smallanthus sonchifolius) in combination with silymarin as food supplements: in vivo safety assessment. Food and Chemical Toxicology 2008;46(3):1006-1013. PubMed Randomised trial
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Sources cited by Health Canada (2)
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
Condition of application: Healthy mood balance; Sexual health.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression (Brotto 2010; Gonzales and Gonzales-Castaneda 2009; Dording et al. 2008).
Sources cited by Health Canada (3)
- Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder in women. Archives of Sexual Behavior 2010;39(2):221-239. PubMed Review article
- Dording CM, Fsher L, Papakostas G, Farabaugh A, Sonawalla S, Fava M, Mischoulon D. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neuroscience Therapy and Therapeutics 2008;14(3):182-191. PubMed Randomised trial
- Gonzales GF, Gonzales-Castaneda GC. The Methyltetrahydro-{beta}-Carbolines in Maca (Lepidium meyenii). Evidence Based Complementary Alternative Medicine 2009;6(3):315-316. PubMed
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Has the product changed? Photograph the packaging.
Brand : LifeSeasons Therapeutics
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Masculini-T (LifeSeasons Therapeutics): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/853760002247-masculini-t-lifeseasons-therapeutics, updated 22 November 2024.